Financings in Brief: ThermoLase
This article was originally published in The Gray Sheet
Executive Summary
ThermoLase: Announces Aug. 18 that it has commenced a public offering of 2.3 mil. common shares of its stock, to be sold for $25.25 each. The San Diego-based firm's offering is being managed by NatWest Securities Limited, Lehman Brothers, and Oppenheimer & Co. ThermoLase, which received clearance earlier this year for its laser-based hair removal system, says that proceeds from the offering will be used for further commercialization of the system. The company is preparing to open a hair removal center in La Jolla, California toward the end of this year. Underwriters have a 30-day over-allotment option to purchase 337,500 shares, ThermoLase says...
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.